🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary study objectives are: * To demonstrate that a 2-dose regimen o...
Status
Completed
Location
Multiple Locations
Start Date
2007-11-29
Trial ID
NCT00566527
Treatments Being Tested
This clinical trial will evaluate the safety of two injections of Menactra®...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT00483574
Healthy children who received two doses of GlaxoSmithKline (GSK) Biological...
Status
Unknown
Location
Multiple Locations
Start Date
2004-07
Trial ID
NCT02712203
Treatments Being Tested
This study will assess the safety and immunogenicity of ProQuad when admini...
Status
Completed
Location
Multiple Locations
Start Date
2000-06
Trial ID
NCT00984295
The proposed study is an Extension Study of V72P13 to Evaluate the Safety, ...
Status
Completed
Location
Altenburger
Start Date
2009-02
Trial ID
NCT00847145
Treatments Being Tested
This study will compare ProQuad™ and concomitant administration of M-M-R™ I...
Status
Terminated
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00839917
The purpose of this study is to evaluate how consistently 3 different manuf...
Status
Not Yet Recruiting
Location
Children's Clinic of Jonesboro, AR
Start Date
2026-08-11
Trial ID
NCT07742644
Treatments Being Tested
The purpose of this study is to assess non-inferiority of two different vac...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-11-09
Trial ID
NCT00969436
Treatments Being Tested
This is a modified single-blind, randomized, parallel-group, comparative, m...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00422292
Follow-up to evaluate the immunogenicity and safety of three production lot...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-07
Trial ID
NCT00406211
Treatments Being Tested